minor-clone mutations in cll patients entering first-line treatment
Published 4 years ago • 148 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
2:05
the role of notch1 mutation in cll
-
1:04
defining high-risk cll: known and emerging mutations
-
2:14
novel approaches to first line cll treatment
-
1:29
the importance of treatment sequencing in cll
-
1:51
cml slide mp4 || hematology
-
2:39
the safety and efficacy of ibrutinib for the treatment of cll
-
3:30
gene therapy basics
-
0:45
key trials in cll and designing a concept for treatment
-
1:59
a strategy for curing cll, one clone at a time
-
1:26
common genetic tests in cll & when these tests should be performed
-
1:28
genomic testing in cll
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
4:29
first-line ibrutinib vs chemoimmunotherapy in cll: a real-world data analysis
-
2:41
btk and plcg2 mutations in cll patients taking ibrutinib
-
1:01
cll resistance mechanisms in the era of novel agents
-
2:37
next steps for genetic testing in cll
-
2:25
update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
1:37
the importance of genomic testing in the diagnosis of cll
-
1:36
using genomics to predict cll progression
-
2:29
the measurement of molecular biomarkers to aid cll treatment